It is estimated that the incidence of<unk>  in the United States is between 1 in 1300 to 4000 live births. While it can affect women of all races, it is more prevalent in some countries; for example, estimates suggest that<unk>  occurs at rates of one in 1000 live births in South African Bantus, and as high as one in 300 in Haiti. Some studies assert that<unk>  may be slightly more prevalent among older women who have had higher numbers of liveborn children and among women of older and younger extremes of childbearing age. However, a quarter to a third of<unk>  patients are young women who have given birth for the first time. While the use of tocolytic agents or the development of preeclampsia (toxemia of pregnancy) and pregnancy-induced hypertension (PIH) may contribute to the worsening of heart failure, they do not cause<unk> ; the majority of women have developed<unk>  who neither received tocolytics nor had preeclampsia nor PIH. In short,<unk>  can occur in any woman of any racial background, at any age during reproductive years, and in any pregnancy.
Peripartum cardiomyopathy
Takotsubo cardiomyopathy
Arrhythmogenic cardiomyopathy
Aicardi syndrome
Sudden arrhythmic death syndrome
Uremic pericarditis
Alcoholic cardiomyopathy
Toxic anterior segment syndrome